ENDRA Life Sciences (NDRA) Other Non-Current Assets (2020 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Other Non-Current Assets of $5986.0 for Q1 2026, down 98.36% year-over-year from $365417.0 in Q1 2025, and down 98.36% quarter-over-quarter from $365417.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Other Non-Current Assets for 7 consecutive years, with $5986.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 98.36% year-over-year to $5986.0; the TTM figure through Mar 2026 stood at $5986.0 (down 98.36% YoY), while the FY2025 annual figure was $365417.0, up 6004.53% from the prior year.
- Other Non-Current Assets declined to $5986.0 in Q1 2026 per NDRA's latest filing, from $365417.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $647085.0 in Q2 2024 and bottomed at $5986.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $224816.5 across 5 years, with a median of $5986.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 8755.13% — and 2024, when it plunged 99.04%.
- ENDRA Life Sciences' Other Non-Current Assets stood at $502576.0 in 2022, then increased by 24.68% to $626610.0 in 2023, then slumped by 99.04% to $5986.0 in 2024, then surged by 6004.53% to $365417.0 in 2025, then plunged by 98.36% to $5986.0 in 2026.
- Business Quant data shows NDRA's Other Non-Current Assets at $5986.0 in Q1 2026, $365417.0 in Q4 2025, and $365417.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | 567.73 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 1.18 Bn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | 558.00 Mn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | 51.00 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | 576.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | 448.88 Mn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 277.00 Mn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | 5,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,986.00 |
| Dec 31, 2025 | 365,417.00 |
| Sep 30, 2025 | 365,417.00 |
| Jun 30, 2025 | 365,417.00 |
| Mar 31, 2025 | 365,417.00 |
| Dec 31, 2024 | 5,986.00 |
| Sep 30, 2024 | 5,986.00 |
| Jun 30, 2024 | 647,085.00 |
| Mar 31, 2024 | 5,986.00 |
| Dec 31, 2023 | 626,610.00 |
| Sep 30, 2023 | 5,986.00 |
| Jun 30, 2023 | 530,068.00 |
| Mar 31, 2023 | 5,986.00 |
| Dec 31, 2022 | 502,576.00 |
| Sep 30, 2022 | 5,986.00 |
| Jun 30, 2022 | 5,986.00 |
| Mar 31, 2022 | 5,986.00 |
| Dec 31, 2021 | 5,986.00 |
| Sep 30, 2021 | 5,986.00 |
| Dec 31, 2020 | 5,986.00 |